Your session is about to expire
← Back to Search
Digital CBT-I for Insomnia (SLEEP-BOOST Trial)
SLEEP-BOOST Trial Summary
This trial aims to improve the sleep quality of older patients undergoing major joint surgery by using a mobile app and wearable device that have been previously tested for treating insomnia.
SLEEP-BOOST Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSLEEP-BOOST Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.SLEEP-BOOST Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
Are there any available vacancies for patient participation in this clinical trial?
"Information available on clinicaltrials.gov indicates that recruitment for this particular trial is currently not ongoing. Despite being first posted on October 31, 2024 and having its latest update on April 16, 2024, the study is presently inactive in terms of patient enrollment. However, it's worth noting that there are a total of 291 active trials actively seeking participants at this time."
What is the primary goal of this medical study?
"The primary aim of this clinical trial is to evaluate the impact of dCBT-I intervention on Insomnia Severity shortly before surgery, during a review session lasting approximately 3 days to 1 week. Secondary endpoints comprise assessing patient Satisfaction with the intervention through a comprehensive survey gauging app effectiveness and likelihood for recommendation to acquaintances or relatives, evaluating Cognition using the tMoCA test via telephone interaction, and monitoring Postoperative Neurocognitive Disorders (NCD) by measuring cognitive alterations from baseline data (equivalent to 1 standard deviation from the mean)."
Share this study with friends
Copy Link
Messenger